CompaniesOtherUpdated Oct 7, 2026
Altay Therapeutics
Private. At Altay Therapeutics, we're unlocking the therapeutic potential of transcription factor inhibition to address serious, underserved diseases.
- Last round
- Not recorded
- Backed by
- Not recorded
- Launched
- Not recorded
- People
- 5
Overview
Updated Oct 7, 2026
Every fact carries a numbered source. Where we can't source something, it says so.
Identity fields from the company record are sourced where a source is recorded; those have no number.
- Headquarters
- SAN CARLOS CALIFORNIA · as of 2026-10-022
- Sector
- Not recorded
- Geography
- SAN CARLOS CALIFORNIA
- Founded
- Not recorded
Funding Not recorded
Opportunities For accredited investors
Ways to invest in this company through an Alphaneo vehicle, when one exists. This section looks the same on every company page until you have an accredited profile.
Opportunities, terms and data rooms are shown to accredited investors. Creating a profile takes two minutes, and you’re notified first when anything opens.
No live opportunities right now. Accredited investors are notified first when one opens.
Create an accredited profileA vehicle is never smaller than $1,000,000.
People
Who founded and leads Altay Therapeutics?
Names and titles only, each sourced.
Sources
Every claim on this page traces to one of these. The numbers match the citations above.
- 1Innovating Therapeutics for Unmet Medical Need opens in a new tabWebsite, People · accessed Oct 6, 2026
- 2SEC Form D — Altay Therapeutics, Inc. opens in a new tabHeadquarters · accessed Oct 6, 2026